Terazosin Hydrochloride Capsule
Product Images NDC 63629-1414

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Terazosin Hydrochloride (NDC 63629-1414). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bryant Ranch Prepack, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Lbl636291414

Label for Terazosin Capsules, USP 5 mg by Bryant Ranch Prepack. The label states the product NDC 63629-1414-1 and the package contains 100 capsules. It includes storage instructions (20° to 25°C), dispensing information, and identifies Aavis Pharmaceuticals Inc. as the manufacturer. The label has QR codes for the package insert and prescribing information.*

FDA Label Image

Chemical Structure (Terazosin Hydrochloride Capsules 1)

Chemical structure of Terazosin Hydrochloride, showing its molecular components with aromatic rings, amine group, piperazine ring, carbamate group, and hydrochloride as part of the compound.*

FDA Label Image

Terazosin Hydrochloride Capsules 2

Two line graphs showing clinical data comparing Terazosin and placebo. The left graph displays mean change in total symptom score from baseline over 3 months, with Terazosin showing a greater decrease than placebo. The right graph shows mean increase in peak flow rate (mL/sec) from baseline over 3 months, with Terazosin showing a higher increase than placebo. Sample sizes and error bars are included.*

FDA Label Image

Terazosin Hydrochloride Capsules 3

A line graph depicting mean change from baseline over 30 months. The X-axis is labeled with time points in months, and the Y-axis shows mean change values. Data points connected by lines indicate a trend of decreasing mean change over time, with asterisks marking certain points.*

FDA Label Image

Terazosin Hydrochloride Capsules 4

A line graph showing the mean change from baseline in an unspecified measurement over a 30-month period, with data points at various months labeled on the x-axis. The y-axis measures the mean change with values ranging from 0.0 to 4.5. Data points show an increasing trend, with statistical significance indicated by asterisks at multiple time points.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.